Role Description The Senior Product Analyst – Digital Transformation (CRO) plays a critical role in advancing SCRI’s digital strategy by translating business priorities into actionable solutions. Serving as the bridge between business stakeholders and IT delivery teams, this role drives operational excellence, data integrity, and innovation at SCRI Development Innovations, a Contract Research Organization (CRO). A key focus is shaping and enabling AI-driven transformation opportunities that deliver measurable business outcomes, with a strong emphasis on hands-on delivery, rapid experimentation, and learning-by-doing through applied digital and AI solutions. Duties & Responsibilities

• Partner with business and IT teams to gather, document, and prioritize requirements, while owning end-to-end problem discovery through pilot delivery for assigned initiatives.
• Participate in cross-functional workshops to identify AI-enabled use cases and iteratively build prototypes, actively configuring, testing, and refining solutions hands-on.
• Translate strategy into user stories, workflows, and specifications for process optimization, and contribute directly to backlog refinement, release planning, and UAT.
• Ensure solutions align with enterprise data strategy, integration needs, 21 CFR Part 11 requirements and responsible AI practices.
• Support change management, documentation, and user enablement for sustainable adoption.
• Document reusable patterns, playbooks, and AI/automation components to accelerate future initiatives and organizational learning.

Qualifications

• 3-5+ years in product or business analysis within dynamic digital transformation environments.
• Demonstrated success supporting healthcare or life sciences product initiatives.
• Ability to rapidly learn new business domains and processes to build strong partnerships.
• Proven track record driving technology adoption and identifying high-value AI opportunities, including directly building or piloting solutions.
• Strong analytical skills with experience reporting progress and outcomes to leadership.
• Experience building low/no-code or AI-enabled proof-of-concept solutions to validate ideas before scale, with personal ownership of prototypes, pilots, or MVPs.

Requirements

• Knowledge of Agile, SDLC, and regulatory considerations in clinical research environments (21 CFR Part 11).
• Awareness of data governance, interoperability standards, and digital adoption analytics.
• Familiarity with coding principles, AI Agentic/automation tools (hands-on preferred), APIs, with the ability to independently configure and test solutions.
• Knowledge of AWS, Azure, and modern research applications vendors such as Veeva, Medidata, Oracle, etc.
• Ability to do hands-on POC with AI tools, ROI analysis for product initiatives, and iterate based on real user and system feedback.

Skills

• Advanced analytical and problem-solving skills to identify business problems, define solution options, and consult with stakeholders to deliver impactful outcomes.
• Proficiency with Microsoft Copilot, AI Agents, and project management tools e.g., Jira, Confluence, Planview, Smartsheets.
• Strong communication skills to translate business needs into clear technical requirements and simplify technical concepts for business stakeholders, while influencing decisions and achieving alignment.
• Skilled in requirements traceability, validation, and driving cross-functional alignment.
• Experience using process-mining and workflow analysis to uncover automation opportunities, and rapidly test those opportunities through prototypes or pilots.

Benefits

• Comprehensive benefits to support physical, mental, and financial well-being.
• Competitive compensation package determined by performance, experience, skills, equity, and geographical markets.
• Annual bonus or long-term incentive opportunities may be offered.

Company Description

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S.